179 related articles for article (PubMed ID: 12460878)
1. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
Rashid S; Uffelman KD; Barrett PH; Lewis GF
Circulation; 2002 Dec; 106(23):2955-60. PubMed ID: 12460878
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
Davidson MH; Ose L; Frohlich J; Scott RS; Dujovne CA; Escobar ID; Bertolami MC; Cihon F; Maccubbin DL; Mercuri M
Clin Cardiol; 2003 Nov; 26(11):509-14. PubMed ID: 14640465
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models.
Krause BR; Newton RS
Atherosclerosis; 1995 Oct; 117(2):237-44. PubMed ID: 8801869
[TBL] [Abstract][Full Text] [Related]
4. Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
Bach-Ngohou K; Ouguerram K; Frénais R; Maugère P; Ripolles-Piquer B; Zaïr Y; Krempf M; Bard JM
J Pharmacol Exp Ther; 2005 Oct; 315(1):363-9. PubMed ID: 16014756
[TBL] [Abstract][Full Text] [Related]
5. Combinational effects of farnesoid X receptor antagonist and statin on plasma lipid levels and low-density lipoprotein clearance in guinea pigs.
Amano Y; Ishikawa E; Shinozawa E; Shimada M; Miura S; Adachi R; Tozawa R
Life Sci; 2014 Jul; 108(1):7-12. PubMed ID: 24805868
[TBL] [Abstract][Full Text] [Related]
6. Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
Briand F; Magot T; Krempf M; Nguyen P; Ouguerram K
Eur J Clin Invest; 2006 Apr; 36(4):224-30. PubMed ID: 16620283
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Vaisman BL; Applebaum-Bowden D; Bérard AM; Talley GD; Brewer HB; Hoeg JM
J Lipid Res; 1997 Dec; 38(12):2537-47. PubMed ID: 9458277
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin.
Auerbach BJ; Krause BR; Bisgaier CL; Newton RS
Atherosclerosis; 1995 Jun; 115(2):173-80. PubMed ID: 7661876
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men.
Mauger JF; Couture P; Paradis ME; Lamarche B
Atherosclerosis; 2005 Jan; 178(1):157-63. PubMed ID: 15585213
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
Asztalos BF; Le Maulf F; Dallal GE; Stein E; Jones PH; Horvath KV; McTaggart F; Schaefer EJ
Am J Cardiol; 2007 Mar; 99(5):681-5. PubMed ID: 17317371
[TBL] [Abstract][Full Text] [Related]
11. Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesity.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Am J Clin Nutr; 2006 Jul; 84(1):37-43. PubMed ID: 16825679
[TBL] [Abstract][Full Text] [Related]
12. Hypocholesterolemic effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in the guinea pig: atorvastatin versus simvastatin.
Conde K; Pineda G; Newton RS; Fernandez ML
Biochem Pharmacol; 1999 Oct; 58(7):1209-19. PubMed ID: 10484079
[TBL] [Abstract][Full Text] [Related]
13. Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease.
Schaefer JR; Schweer H; Ikewaki K; Stracke H; Seyberth HJ; Kaffarnik H; Maisch B; Steinmetz A
Atherosclerosis; 1999 May; 144(1):177-84. PubMed ID: 10381291
[TBL] [Abstract][Full Text] [Related]
14. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.
Burnett JR; Barrett PH; Vicini P; Miller DB; Telford DE; Kleinstiver SJ; Huff MW
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1906-14. PubMed ID: 9848883
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
Parhofer KG; Barrett PH; Schwandt P
J Clin Endocrinol Metab; 2000 Nov; 85(11):4224-30. PubMed ID: 11095458
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
17. Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.
Nicholls SJ; Cutri B; Worthley SG; Kee P; Rye KA; Bao S; Barter PJ
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2416-21. PubMed ID: 16141405
[TBL] [Abstract][Full Text] [Related]
18. Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia.
Maki KC; Bays HE; Dicklin MR; Johnson SL; Shabbout M
J Clin Lipidol; 2011; 5(6):483-92. PubMed ID: 22108152
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.
Dallinga-Thie GM; Berk-Planken II; Bootsma AH; Jansen H;
Diabetes Care; 2004 Jun; 27(6):1358-64. PubMed ID: 15161788
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
